Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00471107 · ClinicalTrials.gov registry record · Phase 1

Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory

A Phase 1 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
Phase 1
Development phase
45
Enrollment target

NCT00471107 is a Phase 1 study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00471107, a Phase 1 study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
Phase 1
Development phase
45 participants
Enrollment target

Study Summary

This study will test the effect of direct current (DC) brain polarization (the application of a very weak electrical current to the brain) on learning and memory. Earlier studies have shown that DC polarization can temporarily improve the ability of healthy people to think of certain words. This study will explore whether it can also temporarily improve learning and memory. Healthy people 18 years of age and older may be eligible for this study. Subjects participate in two experimental sessions at the NIH Clinical Center. The first session lasts about 1 hour; the second session, on the next day, takes about 10 minutes. At the beginning of the first session, electrodes are placed on the subject's head and arm for brain stimulation. The current may be turned on for 25 minutes, or only very briefly (sham stimulation). Subjects are not told which type of stimulation they are receiving. No stimulation is applied in the second session. During the sessions subjects are asked to complete the following tasks that will help elucidate the effects of polarization: * Read a list of words and remember them. Later they will try to repeat the words from memory. * Look at a series of designs and remember them. Later they will try to draw the designs from memory. * Push a button on a keyboard when they see a specific item (for example, when the number 7 appears). * Generate as many words as they can think of that begin with a particular letter of the alphabet. Subjects may be videotaped for some or all of the time during the sessions.

Interventions

  • DEVICE DC brain polarization

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2007-05
Est. Completion 2010-04
Phase Phase 1

What the Registry Record Tells You About NCT00471107

The ClinicalTrials.gov registry entry for NCT00471107 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which DC brain polarization is the first listed.

NCT00471107 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00471107 about?

NCT00471107 is a clinical study titled "Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory". This study will test the effect of direct current (DC) brain polarization (the application of a very weak electrical current to the brain) on learning and memory. Earlier studies have shown that DC polarization can temporarily improve the ability of healthy people to think of certain words. This stu...

What is the current status of trial NCT00471107?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2007-05. Estimated completion is 2010-04.

What interventions are being tested in trial NCT00471107?

The interventions under investigation include: DC brain polarization (DEVICE).

Who is sponsoring clinical trial NCT00471107?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.